BYD stock tumbled in Hong Kong on Monday after price cuts to several models.

Karen Tso takes a deep dive into how tech analysts and investment banks are reacting to President Trump's latest tariff threat against Apple.

TORONTO, ONTARIO, May 26, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today confirmed that its Board of Directors has received a letter from Goodwood Fund and Puccetti Funds Management Inc.(“Goodwood”) regarding six (6) director nominations for the Company's upcoming Annual and Special Meeting of Shareholders.

I rate Commercial Metals Company as a Hold, given a balanced risk/reward profile and current valuation reflecting only modest growth expectations. Strong industry tailwinds exist from infrastructure spending, reshoring, and green construction, but regime uncertainty and tariff risks temper demand visibility. CMC's 100% EAF production, vertical integration, and management alignment support long-term value, yet recent financial performance has deteriorated since 2022.

Lithium America's price-to-book ratio is 0.36x, indicating deep undervaluation. The sell-off may have been partly justified due to the lithium ups and downs, but not entirely. The company has the potential to increase production from 40,000 to 200,000 tonnes of lithium per year. 2025's production is expected to grow by 18% to 37% YoY. The company recently moved its headquarters from Canada to Switzerland in January, signaling better international positioning.

Crescent Capital BDC trades at a significant discount to NAV and offers a high 12.5% yield, but recent performance and total returns have been weak. Rising non-accruals, declining earnings, and weakening distribution coverage raise concerns about portfolio health and dividend sustainability. While the portfolio is diversified and focused on first lien, floating rate debt, higher interest rates are pressuring borrowers and increasing risks.

BITO offers indirect bitcoin exposure with substantial recent payouts, but its dividend policy lacks clarity and reliability for income-focused investors. BITO outperforms option-based income ETFs in total returns, especially during bitcoin bull runs, while preserving more NAV than aggressive yield products like YBIT. Despite futures-based inefficiencies and tracking error, BITO is attractive for investors seeking bitcoin exposure with potential income, especially in brokerage or IRA accounts.

SHEL expects former LNG exporters like Indonesia and Algeria to turn into importers, boosting global demand amid Asia's growing energy needs.

Moderna (NASDAQ: MRNA) has caught the market off guard with a significant recovery in recent days – reaching current levels of approximately $27 after hitting a five-year low of $23.15 last week – following the FDA's decision to continue advising annual COVID-19 vaccinations for high-risk populations. However, this abrupt rally appears to be a singular occurrence – competitors such as Pfizer (NYSE: PFE), Sarepta Therapeutics (NASDAQ: SRPT), and CureVac (NASDAQ:CVAC) did not replicate Moderna's increase – implying the rise was primarily fueled by the FDA guidance rather than a wider sector uptrend.

Chevron's disciplined capital allocation and Guyana assets make it resilient and attractive despite recent earnings pressure and oil price volatility. The pending Hess acquisition offers significant long-term upside, though legal uncertainty with Exxon remains a risk to the deal. Chevron is currently valued as if Hess dilution has already occurred, creating compelling 2026 upside potential with a $165.73 price target.

Jamie Dimon said this week he is expecting a 0% S&P 500 expected EPS growth rate for Q2 '25 by the time reporting starts in July '25. He may not be wrong, but the way the “tariff” discussion has evolved, for the expected +10% S&P 500 EPS growth rate for Q2 '25 to fall all the way to 0% by early July '25 would be pretty extreme indeed. The second quarter has seen more severe revisions than the third quarter, but some of that “severity” is partially due to the Q2 '25 quarter being next to report, and historically, the …

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150184&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your SoundHound AI, Inc. (NASDAQ:SOUN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/soundhound-ai-inc-lawsuit-submission-form?prid=150183&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

Nvidia (NASDAQ: NVDA) will issue its next quarterly dividend on June 27, paying $0.01 per share.

Despite a perceived disappointing Q1 2025, California Water Service Group is undervalued relative to peers and its historical averages, offering a compelling entry point. CWT boasts consistent rate base growth, successful rate case approvals, and a robust capital expenditure plan to drive future earnings. As a Dividend King with 58 consecutive annual increases and a low payout ratio, CWT provides reliable and growing income for investors.

SAN DIEGO , May 26, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Compass Diversified Holdings (NYSE: CODI) publicly traded securities between May 1, 2024 and May 7, 2025, all dates inclusive (the "Class Period"), have until July 8, 2025 to seek appointment as lead plaintiff of the Compass Diversified class action lawsuit. Captioned Augenbaum v.

Copart is a textbook compounding machine, best left to reinvest cash rather than pay dividends, maximizing long-term shareholder value. The company dominates a duopoly in salvage auctions, leveraging technology and land ownership to create a durable competitive moat. Retained earnings have been reinvested at high returns, turning every $1 into over $7 in market value over the past decade.

Abercrombie & Fitch (NYSE: ANF) is set to publish its fiscal first-quarter earnings on Wednesday, May 28, 2025, with analysts expecting earnings of $1.34 per share on revenue of $1.06 billion. This would indicate a 37% decrease in earnings year-over-year and a 4% increase in sales compared to the previous year's figures of $2.14 per share and $1.02 billion in revenue.

RENO, Nev., May 26, 2025 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE: IAUX) ("i-80" or the "Company") is pleased to announce that it has closed the previously announced concurrent private placement (the "Concurrent Private Placement") of 22,240,000 units (the "Units") at a price of US$0.50 per Unit for gross proceeds of US$11,120,000.

Mark Zuckerberg's Meta knew Instagram was steering underage users toward online creeps and other harmful content – even as it shot down requests by cofounder Kevin Systrom and others to commit more resources for safety, according to bombshell documents that surfaced at the FTC's antitrust trial.